Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE)
Clinical trial NCT07670546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07670546
- Sponsor
- R-Pharm International, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-11
- Primary completion
- 2026-04-10
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.